Clinical Trial Update: Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted Dosing [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating genotype-adjusted dosing of omeprazole for gastroesophageal reflux disease, reporting improvement in clinical outcomes; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Omeprazole (Omeprazole)

Snippet

Sponsor: Matthias Schwab | Conditions: Gastroesophageal Reflux | Phase 4 | Status: TERMINATED